Skip to main content
SpringerLink
Log in

In Vitro Fertilization for the Polycystic Ovary Syndrome

  • Chapter
Book cover Androgen Excess Disorders in Women

Part of the book series: Contemporary Endocrinology ((COE))

  • 1723 Accesses

Abstract

In vitro fertilization (IVF) is the final option for fertility treatment of all etiologies and must often be performed on women with polycystic ovaries or polycystic ovary syndrome (PCOS). Many women undergoing IVF are noted to have polycystic ovaries or PCOS. These women have ovaries that are more sensitive to ovarian stimulation, they develop more follicles, produce more oocytes, and are more prone to ovarian hyperstimulation syndrome (OHSS). This may be because of the increased vascularity of the ovaries as exemplified by increased ovarian stromal peak systolic blood flow velocity (Vmax) and increased levels of serum and intrafollicular vascular endothelial growth factor. In order to minimize the risk of OHSS, it is therefore necessary to commence ovarian stimulation with a smaller dose of gonadotropins. An alternative strategy could be to perform in vitro maturation of oocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 269.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet 1978;2:366.

    Article  PubMed  CAS  Google Scholar 

  2. Schultz RM, Williams CJ. The science of ART. Science 2002;296:2188–2190.

    Article  PubMed  CAS  Google Scholar 

  3. Tan SL, Royston P, Campbell S, et al. Cumulative conception and livebirth rates after in vitro fertilisation. Lancet 1992;339:1390–1394.

    Article  PubMed  CAS  Google Scholar 

  4. Klonoff-Cohen H. Female and male lifestyle habits and IVF: what is known and unknown. Hum Reprod Update 2005;11:179–203.

    Article  PubMed  CAS  Google Scholar 

  5. Tan SL, Bennett S, Parsons J. Surgical techniques for oocyte recovery and embryo transfer. British Medical Bulletin 1990;46:628–642.

    PubMed  CAS  Google Scholar 

  6. Brinsden PR, Wada I, Tan SL, Balen A, Jacobs HS. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995;102:767–772.

    PubMed  CAS  Google Scholar 

  7. Tan SL, Maconochie N, Doyle P, et al. Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Am J Obstet Gynecol 1994;171:513–520.

    PubMed  CAS  Google Scholar 

  8. Wright VC, Schieve LA, Reynolds MA, Jeng G. Assisted reproductive technology surveillance-United States, 2002. MMWR Surveill Summ 2005;54:1–24.

    PubMed  Google Scholar 

  9. Engmann L, Maconochie N, Sladkevicius P, Bekir J, Campbell S, Tan SL. The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology. Hum Reprod 1999;14:167–171.

    Article  PubMed  CAS  Google Scholar 

  10. Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries-a common finding in normal women. Lancet 1988;1:870–872.

    Article  PubMed  CAS  Google Scholar 

  11. Abdel Gadir A, Khatim MS, Mowafi RS, Alnaser HM, Muharib NS, Shaw RW. Implications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles. Hum Reprod 1992;7:453–457.

    PubMed  CAS  Google Scholar 

  12. Clayton RN, Ogden V, Hodgkinson J, et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol (Oxf) 1992;37:127–134.

    CAS  Google Scholar 

  13. MacDougall MJ, Tan SL, Balen A, Jacobs HS. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod 1993;8:233–237.

    PubMed  CAS  Google Scholar 

  14. Dunaif A, Graf M. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J Clin Invest 1989;83:23–29.

    Article  PubMed  CAS  Google Scholar 

  15. Dale O, Tanbo T, Haug H, Abyholm T. The impact of insulin resistance on the outcome of ovulation induction withlow dose FSH in women with polycystic ovary syndrome. Hum Reprod 1998;13:567–570.

    Article  PubMed  CAS  Google Scholar 

  16. Fedorcsak P, Dale PO, Storeng R, Abyholm T, Tanbo T. The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial. Gynecol Endocrinol 2003;17:207–214.

    Article  PubMed  CAS  Google Scholar 

  17. Stadtmauer LA, Toma SK, Riehl RM, Talbert LM. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril 2001;75:505–509.

    Article  PubMed  CAS  Google Scholar 

  18. Stadtmauer LA, Toma SK, Riehl RM, Talbert LM. Impact of metformin therapy on ovarian stimulation and outcome in ‘coasted’ patients with polycystic ovary syndrome undergoing in-vitro fertilization. Reprod Biomed Online 2002;5:1 12–116.

    Article  CAS  Google Scholar 

  19. Kjotrod SB, von During V, Carlsen SM. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Hum Reprod 2004;19:1315–1322.

    Article  PubMed  CAS  Google Scholar 

  20. Onalan G, Pabuccu R, Goktolga U, Ceyhan T, Bagis T, Cincik M. Metformin treatment in patients with polycystic ovary syndrome undergoing in vitro fertilization: a prospective randomized trial. Fertil Steril 2005;84:798–801.

    Article  PubMed  CAS  Google Scholar 

  21. Fedorcsak P, Dale PO, Storeng R, Tanbo T, Abyholm T. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome. Hum Reprod 2001;16:1086–1091.

    Article  PubMed  CAS  Google Scholar 

  22. Biljan MM, Mahutte NG, Dean N, Hemmings R, Bissonnette F, Tan SL. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil Steril 1998;70:1063–1069.

    Article  PubMed  CAS  Google Scholar 

  23. Smitz J, Ron-El R, Tarlatzis BC. The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres. Hum Reprod 1992;7(Suppl 1):49–66.

    PubMed  Google Scholar 

  24. Balen AH, Tan SL, MacDougall J, Jacobs HS. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod 1993;8:959–964.

    PubMed  CAS  Google Scholar 

  25. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988;297:1024–1026.

    Article  PubMed  CAS  Google Scholar 

  26. Homburg R, Berkowitz D, Levy T, Feldberg D, Ashkenazi J, Ben-Rafael Z. In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril 1993;60:858–863.

    PubMed  CAS  Google Scholar 

  27. Stanger JD, Yovich JL. Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 1985;92:385–393.

    PubMed  CAS  Google Scholar 

  28. .Howles CM, Macnamee MC, Edwards RG, Goswamy R, Steptoe PC. Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation. Lancet 1986;2:521–522.

    Article  PubMed  CAS  Google Scholar 

  29. Zaidi J, Campbell S, Pittrof R, et al. Ovarian stromal blood flow in women with polycystic ovaries-a possible new marker for diagnosis? Hum Reprod 1995;10:1992–1996.

    Article  PubMed  CAS  Google Scholar 

  30. Zaidi J, Jacobs H, Campbell S, Tan SL. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations. Ultrasound Obstet Gynecol 1998;12:188–196.

    Article  PubMed  CAS  Google Scholar 

  31. Buckett WM, Bouzayen R, Watkin KL, Tulandi T, Tan SL. Ovarian stromal echogenicity in women with normal and polycystic ovaries. Hum Reprod 1999;14:618–621.

    Article  PubMed  CAS  Google Scholar 

  32. Agrawal R, Conway G, Sladkevicius P, et al. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil Steril 1998;70:651–658.

    Article  PubMed  CAS  Google Scholar 

  33. McClure N, Healy DL, Rogers PA, et al.. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994;344:235–236.

    Article  PubMed  CAS  Google Scholar 

  34. Smitz J, Camus M, Devroey P, Erard P, Wisanto A, Van Steirteghem AC. Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. Hum Reprod 1990;5:933–937.

    PubMed  CAS  Google Scholar 

  35. Forman RG, Frydman R, Egan D, Ross C, Barlow DH. Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention. Fertil Steril 1990;53:502–509.

    PubMed  CAS  Google Scholar 

  36. MacDougall MJ, Tan SL, Jacobs HS. In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod 1992;7:597–600.

    PubMed  CAS  Google Scholar 

  37. Sher G, Zouves C, Feinman M, Maassarani G. ‘Prolonged coasting’: an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum Reprod 1995;10:3107–3109.

    PubMed  CAS  Google Scholar 

  38. Orvieto R. Can we eliminate severe ovarian hyperstimulation syndrome? Hum Reprod 2005;20:320–322.

    Article  PubMed  Google Scholar 

  39. Chen CD, Wu MY, Yang JH, Chen SU, Ho HN, Yang YS. Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome. Fertil Steril 1997;68:287–291.

    Article  PubMed  CAS  Google Scholar 

  40. Tan SL, Balen A, el Hussein E, Campbell S, Jacobs HS. The administration of glucocorticoids for the prevention of ovarian hyperstimulation syndrome in in vitro fertilization: a prospective randomized study. Fertil Steril 1992;58:378–383.

    PubMed  CAS  Google Scholar 

  41. Chian RC, Buckett WM, Too LL, Tan SL. Pregnancies resulting from in vitro matured oocytes retrieved from patients with polycystic ovary syndrome after priming with human chorionic gonadotropin. Fertil Steril 1999;72:639–642.

    Article  PubMed  CAS  Google Scholar 

  42. Tan SL, Child TJ, Gulekli B. In vitro maturation and fertilization of oocytes from unstimulated ovaries: predicting the number of immature oocytes retrieved by early follicular phase ultrasonography. Am J Obstet Gynecol 2002;186:684–689.

    Article  PubMed  Google Scholar 

  43. Child TJ, Abdul-Jalil AK, Gulekli B, Tan SL. In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome. Fertil Steril 2001;76:936–942.

    Article  PubMed  CAS  Google Scholar 

  44. Chian RC, Gulekli B, Buckett WM, Tan SL. Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome. N Engl J Med 1999;341:1624, 1626.

    Article  PubMed  CAS  Google Scholar 

  45. Chian RC, Buckett WM, Tan SL. In-vitro maturation of human oocytes. Reprod Biomed Online 2004;8:148–166.

    Article  PubMed  Google Scholar 

  46. Chian RC, Buckett WM, Abdul Jalil, et al. Natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes is a potential approach i+n infertility treatment. Fertil Steril 2004;82:1675–1678.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada

    Hanadi Ba-Akdah

  2. Department of Obstetrics and Gynecology, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada

    Ezgi Demirtas

  3. Department of Obstetrics and Gynecology, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada

    Hananel Holzer

  4. Department of Obstetrics and Gynecology, McGillUniversity, Royal Victoria Hospital, Montreal, Quebec, Canada

    William Buckett

  5. Department of Obstetricsand Gynecology, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada

    Seang Lin Tan

Authors
  1. Hanadi Ba-Akdah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ezgi Demirtas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hananel Holzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William Buckett
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seang Lin Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Center for Androgen Related Disorders, Cedars-Sinai Medical Center; and Department of Obstetrics and Gynecology, and Department of Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, CA

    Ricardo Azziz MD, MPH, MBA

  2. Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA

    John E. Nestler MD

  3. Department of Endocrine Gynaecology and Reproductive Medicine, Lille University Hospital, Lille, France

    Didier Dewailly MD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Ba-Akdah, H., Demirtas, E., Holzer, H., Buckett, W., Tan, S.L. (2006). In Vitro Fertilization for the Polycystic Ovary Syndrome. In: Azziz, R., Nestler, J.E., Dewailly, D. (eds) Androgen Excess Disorders in Women. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-59745-179-6_36

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-179-6_36

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-663-4

  • Online ISBN: 978-1-59745-179-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation